Immunology->Innate Immunity->Macrophage / Inflamm;Immunology->Innate Immunity->Cytokines->Interleukins;Cancer->Invasion/microenvironment->Apoptosis->Death receptors & ligands->RIP;Cancer->Invasion/microenvironment->Angiogenesis->Angiogenic growth factors;Cancer->Invasion/microenvironment->Angiogenesis->ECM enzymes->TIMPs;Cancer->Tumor immunology->Cytokines->Interleukins

SwissProt: P29460 Human;SwissProt: P29459 Human

The protein has a predicted MW of 34.7(IL12B/P40) /25.5 (P35/IL12A) kDa.Due to glycosylation, the protein migrates to 45/40 KDa based on Bis-Tris PAGE result.

Human

Protein

> 95% as determined by Bis-Tris PAGE.> 95% as determined by HPLC.

CLMF ; CLMF2 ; IL-12A; IL-12B ; IL12 ; IL12 p70 ; IMD28; IMD29 ; NFSK; NKSF ; NKSF1 ; NKSF2; P35

The product should be stored at -70℃. Please do not repeated freeze-thaw cycles.